Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide Extension Study in Newly Diagnosed Partial Seizures
NCT00848549Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of zonisamide in focal seizures, sponsored by Eisai Co., Ltd.. Started Oct 2008; status: completed.
02
Drugs
zonisamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00848549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848549.